Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Yan Li,1 Xiaomin Wang,2 Edward O’Mara,1 Meletios A Dimopoulos,3 Pieter Sonneveld,4 Katja C Weisel,5 Jeffrey Matous,6 David S Siegel,7 Jatin J Shah,8 Elisabeth Kueenburg,9 Lars Sternas,9 Chloe Cavanaugh,9 Mohamed Zaki,9 Maria Palmisano,1 Simon Zhou1 1Translational Development and C...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Format: article
Language:EN
Published: Dove Medical Press 2017
Subjects:
hemodialysis
pomalidomide
population pharmacokinetics
renal impairment
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/8582ebb39ceb4fcd9b07b7d44a784b3f
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/8582ebb39ceb4fcd9b07b7d44a784b3f

Similar Items